Back

Unlocking survival: assessment of potassium levels in heart failure with quadruple guideline directed medical therapy across all ejection fraction spectrum

11 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - epidemiology, prognosis, outcome 2 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Inci Tugce Colluoglu

Dokuz Eylul University, Izmir (Turkiye)

3 More presentations in this session

Presentation thumbnail
Understanding factors associated with left ventricular ejection fraction improvement in heart failure: a single-centre analysis
Doctor C. Miguel Goncalves (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
The value of the beta2 adrenergic receptor genotype in the prognostic assessment of heart failure
Assistant Professor A. Pereira Da Silva Oliveira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Predicting mortality with ePM-years Index in patients with heart failure and obstructive chronic coronary syndrome
Doctor A. Kurasz (Bialystok, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - epidemiology, prognosis, outcome 2

The Event

Event poster

Heart Failure 2024

11 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of hyperkalemia and mineralocorticoid receptor antagonist use in heart failure: a national registry study
thumbnail
Congress Presentation
Hypokalemia during hospitalization: a strong predictor of mortality in acute heart failure
thumbnail
Congress Presentation
Hyperkalemia, clinical outcomes, and mineralocorticoid receptor antagonist in heart failure: insights from the REVIEW-HF registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources